1. Association of recently described adipokines with liver histology in biopsy‐proven non‐alcoholic fatty liver disease: a systematic review. (24th November 2015) Authors: Bekaert, M.; Verhelst, X.; Geerts, A.; Lapauw, B.; Calders, P. Journal: Obesity reviews Issue: Volume 17:Number 1(2016:Jan.) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study. (February 2020) Authors: Anstee, Q.M.; Harrison, S.; Sanyal, Arun J.; Ratziu, V.; Rinella, M.; Younossi, Z.Y.; Boursier, J.; Francque, S.; Geerts, A.; Petta, S.; Bugianesi, E-; Romero-Gomez, M.; Schattenberg, J.M.; Sarkar, S.; Bonacini, M.; Yataco, M.; Porayko, M.; Siddique, A.; Dufour, J.; Ferro, T. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma. (16th October 2018) Authors: Degroote, H.; Van Dierendonck, A.; Geerts, A.; Van Vlierberghe, H.; Devisscher, L. Other Names: Neagu Monica Guest Editor. Journal: Journal of immunology research Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Surgical microwave ablation of primary and secondary liver tumours: iconographic follow-up and local control. (September 2018) Authors: Abreu de Carvalho, L.F.; Sagaama, S.; Maes, H.; Laurent, S.; De Man, M.; Geerts, A.; Geboes, K.; Van Vlierberghe, H.; Troisi, R.I. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. T06.01.12 OBETICHOLIC ACID (OCA) IMPROVES NON-INVASIVE MARKERS OF FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH): A SECONDARY ANALYSIS OF THE PHASE 3 REGENERATE STUDY. (1st October 2020) Authors: Anstee, Q.M.; Harrison, S.; Sanyal, A.J.; Ratziu, V.; Rinella, M.; Younossi, Z.Y.; Boursier, J.; Francque, S.; Geerts, A.; Petta, S.; Bugianesi, E.; Romero-Gomez, M.; Schattenberg, J.M.; Sarkar, S.; Bonacini, M.; Yataco, M.; Porayko, M.; Siddique, A.; Dufour, J.; Ferro, T. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗